CJC-1295 w/o DAC + IPA
Preclinical — Animal / cell-model data onlyWhat it is
A pre-combined blend of CJC-1295 (no DAC) with ipamorelin, two commonly-paired GH-release research peptides.
A pre-combined blend of CJC-1295 (no DAC) with ipamorelin — the classic GHRH + GHRP pairing in one vial.
Research context
Studied in relation to:
- GH-release research
Points in its favour in the literature:
- Convenient common pairing
Caveats and unknowns:
- Combined human data absent
- Unlicensed for human use
- Prohibited in sport
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Reported half-lifeshort (~30 min)
Published clinical / research context (not instructions)Commonly ~100 mcg of each per dose.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 10 mg total + 2 mL → 5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 10mg | CP10 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.